$383 Million is the total value of Ghost Tree Capital, LLC's 39 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ASND | New | ASCENDIS PHARMA A Sput | $21,775,000 | – | 185,000 | +100.0% | 5.69% | – |
| BPMC | New | BLUEPRINT MEDICINES CORP | $19,212,000 | – | 240,000 | +100.0% | 5.02% | – |
| CBAY | New | CYMABAY THERAPEUTICS INC | $9,960,000 | – | 750,000 | +100.0% | 2.60% | – |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO Lcall | $9,007,000 | – | 175,000 | +100.0% | 2.35% | – |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $8,799,000 | – | 700,000 | +100.0% | 2.30% | – |
| RARX | New | RA PHARMACEUTICALS INC | $6,720,000 | – | 300,000 | +100.0% | 1.76% | – |
| DBVT | New | DBV TECHNOLOGIES S Asponsored adr | $6,554,000 | – | 850,000 | +100.0% | 1.71% | – |
| EPZM | New | EPIZYME INC | $6,195,000 | – | 500,000 | +100.0% | 1.62% | – |
| CHRS | New | COHERUS BIOSCIENCES INC | $6,138,000 | – | 450,000 | +100.0% | 1.60% | – |
| AXSM | New | AXSOME THERAPEUTICS INC | $4,411,000 | – | 310,000 | +100.0% | 1.15% | – |
| CHMA | New | CHIASMA INC | $3,640,000 | – | 700,000 | +100.0% | 0.95% | – |
| SLDB | New | SOLID BIOSCIENCES INC | $920,000 | – | 100,000 | +100.0% | 0.24% | – |
| FGEN | New | FIBROGEN INC | $625,000 | – | 11,500 | +100.0% | 0.16% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2020-04-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.